Management of patients with non-ischaemic cardiomyopathy.
作者信息
Wu Audrey H
机构信息
University of Michigan Hospitals, Women's Hospital, Ann Arbor, MI 48109-0271, USA.
出版信息
Heart. 2007 Mar;93(3):403-8. doi: 10.1136/hrt.2005.085761.
Abstract
摘要
相似文献
1
Management of patients with non-ischaemic cardiomyopathy.非缺血性心肌病患者的管理
Heart. 2007 Mar;93(3):403-8. doi: 10.1136/hrt.2005.085761.
2
Epidemiology and clinical management of cardiomyopathies and heart failure in China.中国心肌病与心力衰竭的流行病学及临床管理
Heart. 2009 Nov;95(21):1727-31. doi: 10.1136/hrt.2008.150177. Epub 2009 Mar 23.
3
Effective management of congestive cardiomyopathy. Relation to ventricular structure and function.充血性心肌病的有效管理。与心室结构和功能的关系。
Arch Intern Med. 1982 Apr;142(4):689-92.
4
[Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].[非缺血性心肌病的风险分层：病例报告——病例5/2010]
Dtsch Med Wochenschr. 2010 Jun;135(22):1122. doi: 10.1055/s-0030-1247612. Epub 2010 May 31.
5
Clinical management of gravid women with peripartum cardiomyopathy.围产期心肌病孕妇的临床管理
Obstet Gynecol Clin North Am. 1991 Jun;18(2):257-71.
6
Successful treatment of tachycardia-induced cardiomyopathy with LVAD in a 12-year-old boy.一名12岁男孩通过左心室辅助装置成功治疗心动过速性心肌病。
Ann Thorac Surg. 2005 Aug;80(2):e5-7. doi: 10.1016/j.athoracsur.2005.04.023.
7
Cardiomyopathy.心肌病
Am J Nurs. 1989 Jan;89(1):57-74B.
8
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.左心室辅助装置植入后正性肌力支持的持续时间：危险因素及其对预后的影响。
J Thorac Cardiovasc Surg. 2006 Feb;131(2):447-54. doi: 10.1016/j.jtcvs.2005.09.031.
9
[Cardiomyopathies].[心肌病]
Arq Bras Cardiol. 1998 Aug;71(2):95-107.
10
[Cirrhotic cardiomyopathy].[肝硬化性心肌病]
Korean J Hepatol. 2007 Mar;13(1):20-6.
引用本文的文献
1
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.从利钠肽到微小RNA：心力衰竭中的多分析物液体活检前景
Biomolecules. 2025 Aug 19;15(8):1189. doi: 10.3390/biom15081189.
2
Radiomic Cardiac MRI Signatures for Predicting Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy.用于预测非缺血性扩张型心肌病患者室性心律失常的放射组学心脏磁共振成像特征
JACC Adv. 2025 Apr;4(4):101684. doi: 10.1016/j.jacadv.2025.101684. Epub 2025 Mar 23.
3
Impact of Heart Failure Team on Inpatient Rapid Sequencing of Heart Failure Therapy.心力衰竭团队对心力衰竭治疗住院快速排序的影响。
J Cardiovasc Dev Dis. 2025 Jan 28;12(2):50. doi: 10.3390/jcdd12020050.
4
Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool.信号平均心电图作为评估非缺血性心肌病患者心室基质的一种非侵入性工具：对一种旧工具的重新评估。
Front Cardiovasc Med. 2024 Apr 16;11:1306055. doi: 10.3389/fcvm.2024.1306055. eCollection 2024.
5
Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.心力衰竭患者炎症与无事件生存之间关联的性别差异。
J Cardiovasc Nurs. 2022;37(4):386-393. doi: 10.1097/JCN.0000000000000831. Epub 2021 Jul 8.
6
Transformational Applications of Human Cardiac Organoids in Cardiovascular Diseases.人类心脏类器官在心血管疾病中的转化应用
Front Cell Dev Biol. 2022 Jun 9;10:936084. doi: 10.3389/fcell.2022.936084. eCollection 2022.
7
Non Ischemic Cardiomyopathy in a 54-Year-Old Khat Consuming Yemeni Male Presenting with Worsening Exertional Dyspnea, T Wave Inversions in V5-V6 and Normal Coronary Artery Angiography.一位 54 岁的也门男性因吸食阿拉伯茶而出现非缺血性心肌病，表现为进行性劳力性呼吸困难，V5-V6 导联 T 波倒置，冠状动脉造影正常。
Am J Case Rep. 2022 Jul 5;23:e935601. doi: 10.12659/AJCR.935601.
8
Surgical management of patient with left ventricular aneurysm and ventricular tachycardia.左心室室壁瘤合并室性心动过速患者的外科治疗
SAGE Open Med Case Rep. 2021 Dec 17;9:2050313X211065881. doi: 10.1177/2050313X211065881. eCollection 2021.
9
Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy.塞尔维斯特评分可预测非缺血性心肌病患者植入式心律转复除颤器的电击次数。
J Arrhythm. 2021 Jun 7;37(4):1046-1051. doi: 10.1002/joa3.12571. eCollection 2021 Aug.
10
The contemporary trends and geographic variation in premature mortality due to heart failure from 1999 to 2018 in the United States.1999年至2018年美国因心力衰竭导致过早死亡的当代趋势及地理差异。
Int J Cardiol Heart Vasc. 2021 Jun 7;34:100812. doi: 10.1016/j.ijcha.2021.100812. eCollection 2021 Jun.
本文引用的文献
1
Cardiac resynchronization therapy: Part 1--issues before device implantation.心脏再同步治疗：第1部分——装置植入前的问题。
J Am Coll Cardiol. 2005 Dec 20;46(12):2153-67. doi: 10.1016/j.jacc.2005.09.019.
2
Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.奈西立肽治疗失代偿性心力衰竭后的短期死亡风险：随机对照试验的汇总分析
JAMA. 2005 Apr 20;293(15):1900-5. doi: 10.1001/jama.293.15.1900.
3
The effect of cardiac resynchronization on morbidity and mortality in heart failure.心脏再同步化治疗对心力衰竭患者发病率和死亡率的影响。
N Engl J Med. 2005 Apr 14;352(15):1539-49. doi: 10.1056/NEJMoa050496. Epub 2005 Mar 7.
4
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.硝酸异山梨酯与肼苯哒嗪联合用于黑人心力衰竭患者
N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.
5
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的预防性除颤器植入
N Engl J Med. 2004 May 20;350(21):2151-8. doi: 10.1056/NEJMoa033088.
6
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.坎地沙坦对不能耐受血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM替代试验
Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5.
7
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.坎地沙坦对正在服用血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM-Added试验
Lancet. 2003 Sep 6;362(9386):767-71. doi: 10.1016/S0140-6736(03)14283-3.
8
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.卡维地洛或美托洛尔欧洲试验（COMET）中卡维地洛与美托洛尔对慢性心力衰竭患者临床结局的比较：随机对照试验
Lancet. 2003 Jul 5;362(9377):7-13. doi: 10.1016/S0140-6736(03)13800-7.
9
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.静脉注射奈西立肽（一种利钠肽）治疗失代偿性充血性心力衰竭。奈西立肽研究小组。
N Engl J Med. 2000 Jul 27;343(4):246-53. doi: 10.1056/NEJM200007273430403.
10
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.血管紧张素转换酶抑制剂赖诺普利低剂量和高剂量对慢性心力衰竭发病率和死亡率的比较影响。ATLAS研究组
Circulation. 1999 Dec 7;100(23):2312-8. doi: 10.1161/01.cir.100.23.2312.
Zotero 插件